Athanor Capital, LP Ac Immune Sa Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $127,522 - $176,715	-21,113 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.32 - $8.96 $387,641 - $652,870	-72,865 Reduced 77.53%	21,113 $161,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $31,442 - $59,596	6,578 Added 7.53%	93,978 $459,000
Q2 2020 Aug 13, 2020	BUY	$6.57 - $8.3 $97,840 - $123,603	14,892 Added 20.54%	87,400 $588,000
Q1 2020 May 14, 2020	SELL	$4.24 - $9.89 $84,223 - $196,454	-19,864 Reduced 21.5%	72,508 $501,000
Q4 2019 Feb 14, 2020	SELL	$4.56 - $8.78 $73,726 - $141,955	-16,168 Reduced 14.9%	92,372 $787,000
Q3 2019 Nov 14, 2019	BUY	$4.8 - $5.89 $318,912 - $391,331	66,440 Added 157.81%	108,540 $537,000
Q2 2019 Aug 13, 2019	BUY	$4.72 - $5.88 $198,712 - $247,548	42,100 New	42,100 $234,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $284M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.